RAIDEN RESOURCES LIMITED — Capital/Financing Update 2006

Aug 14, 2006

Update on Medical Monitors' International Distributor's Merger and NASDAQ OTC Listing

~ GIMU offer to acquire MDM's IP for USD $4.0 million in shares ~

Sydney, Australia: 15 August 2006: Medical Monitors (ASX: MDM) today announced that the reverse merger of its international distribution company. Primedical International Limited (PMI) with Global Immune Technologies, Inc. (GIMU) is being registered with the US Securities Exchange Commission. GIMU is listed on the OTC Bulletin Board of NASDAQ and will be renamed Primedical International Holdings, Inc. (Primedical).

As per MDM's announcement on 1 August, it is GIMU's intention to acquire PMI and its wholly-owned subsidiary, iCardia Healthcare Corporation, the North American cardiac monitoring service, for a combination of convertible debt and equity.

MDM has signed an agreement with GIMU, subject to shareholder approval, for the transfer of the relevant intellectual property (IP) to Primedical to support its distribution of product into the worldwide markets. In the agreement, GIMU has made an offer of USD $4.0 million in shares in the newly merged Primedical for the transfer of IP.

The benefits of the overall transaction to MDM shareholders will be:

• MDM shareholders will be offered a free entitlement of Primedical Common Shares pro-rata to $\blacksquare$ their MDM shareholding by way of an anticipated return of capital de-merger to be distributed to the shareholders before 30 June 2007
• MDM's original shareholding in PMI will be converted pro-rata to Common Shares in the $\blacksquare$ merged company, Primedical
• Primedical will continue to distribute MDM's cutting edge Australian designed technology to the US monitoring market, which according to Frost and Sullivan for all monitoring devices in 2004 was worth US$296million and the associated services market was worth up to US$3.24 billion. Importantly, this will result in a significant reduction of at least 50 per cent in MDM overheads this financial year.

The acquisition and share allocation is subject to MDM shareholder approval, to be sought at a forthcoming general meeting, on a date to be advised. Detailed information will be provided in a Notice of Meeting to be sent to all shareholders.

MDM's Agreement with Primedical

The consideration for the GIMU's acquisition of PMI's business and subsidiaries is outlined in three stages:

$\ddagger$ . 74 million new Primedical Common Shares will be issued to PMI. The existing GIMU shareholders currently hold 16 million Common Shares. MDM had a retained equity in PMI for its original Licence and Distribution agreements. This represents an allocation of approximately 21.3 million of the 74 million new Primedical Common Shares to Medical Monitors' shareholders.

Medical Monitors Limited Suite 407 Westfield Eastgardens Eastgardens NSW 2036 Tel (02) 9344 8100 Fax (02) 9344 8200 Web site: www.medmon.com.au

• $\overline{2}$ . US$10 million will be issued in a convertible note, at a minimum price of US$0.40 cents, providing an additional pro-rata allocation of 9.3 million Primedical Common Shares to Medical Monitors' shareholders.
• US$4 million will be issued in a convertible note, at a minimum of US$0.40 cents, providing an $\mathcal{R}$ additional pro-rata allocation of 10 million shares to Medical Monitors for the acquisition of its IP by Primedical.

At the conversion of both convertible notes and the initial consideration, MDM will retain in total approximately 30 per cent equity in Primedical, partially diluted, prior to other financing, debt conversion and proposed MDM shareholder distribution.

Dr Allan Shell, Managing Director of MDM, said: "Our retained equity position in Primedical will provide Medical Monitors with an increased portfolio of assets. It will also allow shareholders to participate in a capital distribution, once all shares have been registered and approved."

"Most importantly, the acquisition will result in a siginificant increase in shareholder value," added Dr Shell

For further information, please contact:

Media relations	Medical Monitors
Daniella Goldberg	Dr Allan Shell
+61 2 9237 2800	Managing Director
dgoldberg@bcg.com.au	+ 612 9344 8100
Investor relations	ashell@medmon.com.au
Rebecca Piercy
+612 9237 2800
rpiercy@bcq.com.au

About Medical Monitors:

Medical Monitors (ASX: MDM) is a health sector company generating revenue from investment in medical technology and resort lifestyle property for the over 50s. The company specialises in home-based medical monitoring technology which allow doctors to remotely monitor the cardiovascular health of their patients. The technologies have been granted US Food and Drug Administration (FDA) registration to enable marketing and sales. (www.medmon.com.au)

About Primedical International:

The merged Company, to be named Primedical International Holdings, Inc., will have newly appointed Directors and will be engaged in the business of telemedicine and remote ambulatory monitoring. The Company will acquire iCardia Healthcare Corporation, located in Lake Forest, Illinois, which has revolutionized the ECG monitoring service marketplace with its unique 'single-use' approach to ECG monitoring, creating unprecedented convenience for physicians and new levels of security for patients.

Primedical's strategy is to rapidly grow its current business in North America through iCardia, and to expand into Europe using MDM's cutting edge Australian designed technology for the US arrhythmia monitoring market. Frost and Sullivan have estimated that the US market for all monitoring devices in 2004 was worth US$296million and that the associated services market was worth up to US$3.24 billion. (www.primedical.com)

About iCardia Healthcare Corporation:

iCardia's Single Use Patient Event Recorder (suPER) and proprietary application systems were developed by Medical Monitors and provide groundbreaking innovations in the diagnosis and treatment of cardiac arrhythmias. The lightweight, simple monitor boosts patient compliance, is absolutely hygienic and delivers high quality data. The service rapidly receives ECG transmissions and produces reports that can be viewed. annotated, and stored electronically, thereby enhancing analysis, interpretation, and mean time to diagnosis.(www.icardia.com)

Medical Monitors Limited Suite 407 Westfield Eastgardens Eastgardens NSW 2036 Tel (02) 9344 8100 Fax (02) 9344 8200 Web site: www.medmon.com.au